Literature DB >> 22816318

Ischemia-reperfusion increases transfection efficiency of intracoronary adenovirus type 5 in pig heart in situ.

Weiwei Shi1, L Susan Schmarkey, Rong Jiang, C Collin Bone, Marah E Condit, Dirck L Dillehay, Robert L Engler, Gabor M Rubanyi, Jakob Vinten-Johansen.   

Abstract

Efficiency of intracoronary (IC) adenoviral vector transfection is impaired by the vascular endothelium. Ischemia and substances that increase vascular permeability (sodium nitroprusside, nitroglycerin) may augment adenoviral vector transfection efficiency (TE). We tested whether TE of adenoviral vector following IC infusion is improved by nitrates or by ischemia. Fluoroscopically guided angioplasty balloon catheters occluded the coronary artery in Yorkshire pigs and delivered adenoviral type 5 vector encoding the luciferase gene (Ad5Luc, 10(11) viral particles). TE (luciferase activity) was minimal and was not augmented by IC co-administration of 50 μg/min sodium nitroprusside to nonischemic myocardium. Two (but not one) 3-min episodes of occlusion tended to increase luciferase activity (p=0.06), and luciferase activity was further increased by IC co-administration of nitroglycerin (p<0.001). After 75 min of coronary artery occlusion, luciferase activity was greater than with shorter periods of ischemia, and was significantly greater in the ischemia-reperfused zone compared to the border zone 3 and 14 days after infusion; there was no transfection in nonischemic myocardium. IC delivery of Ad5Luc into post-ischemic myocardium caused no local inflammation or hemodynamic instability. We conclude that the uptake of IC Ad5 to ischemic reperfused myocardium validates use of IC Ad5 delivery protocols in future human gene therapy trials in patients following myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22816318      PMCID: PMC4015071          DOI: 10.1089/hgtb.2012.048

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  27 in total

1.  Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate.

Authors:  Sitaram M Emani; Ashish S Shah; Michael K Bowman; Sitaramesh Emani; Katrina Wilson; Donald D Glower; Walter J Koch
Journal:  Mol Ther       Date:  2003-08       Impact factor: 11.454

2.  Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism.

Authors:  Henry Fechner; Michel Noutsias; Carsten Tschoepe; Kerstin Hinze; Xiaomin Wang; Felicitas Escher; Matthias Pauschinger; Dick Dekkers; Roland Vetter; Martin Paul; Jos Lamers; Heinz-Peter Schultheiss; Wolfgang Poller
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

3.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

4.  Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.

Authors:  Alan R Brooks; Richard N Harkins; Peiyin Wang; Hu Sheng Qian; Pengxuan Liu; Gabor M Rubanyi
Journal:  J Gene Med       Date:  2004-04       Impact factor: 4.565

5.  A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.

Authors:  Cindy L Grines; Matthew W Watkins; John J Mahmarian; Ami E Iskandrian; Jeffrey J Rade; Pran Marrott; Craig Pratt; Neal Kleiman
Journal:  J Am Coll Cardiol       Date:  2003-10-15       Impact factor: 24.094

6.  Coronary vascular hemodynamic and permeability changes during reperfusion after no-flow ischemia in isolated, diltiazem-treated rabbit hearts.

Authors:  R G Tilton; E K Williamson; P A Cole; K B Larson; C Kilo; J R Williamson
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

7.  Tracer exchange in the normal and ischemic coronary circulation.

Authors:  T R Harris; K A Overholser; J C Collins
Journal:  Fed Proc       Date:  1984-02

8.  In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart.

Authors:  M Iwatate; Y Gu; T Dieterle; Y Iwanaga; K L Peterson; M Hoshijima; K R Chien; J Ross
Journal:  Gene Ther       Date:  2003-10       Impact factor: 5.250

9.  Preexisting antiadenoviral immunity and regional myocardial gene transfer: modulation by nitric oxide.

Authors:  Zsolt Szelid; Peter Sinnaeve; Pieter Vermeersch; Hilde Gillijns; Marijke Pellens; Veerle Laurysens; Natascha Van Pelt; Willem Flameng; Paul Sergeant; Paul Herijgers; Peter Pokreisz; Anton-Jan Van Zonneveld; Erik Verbeken; Desire Collen; Stefan Janssens
Journal:  Hum Gene Ther       Date:  2002-12-10       Impact factor: 5.695

10.  Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits.

Authors:  R G Tilton; A Daugherty; S P Sutera; K B Larson; M P Land; D L Rateri; C Kilo; J R Williamson
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

View more
  4 in total

Review 1.  Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.

Authors:  Schwartze Jt; Havenga M; Bakker Wam; Bradshaw Ac; Nicklin Sa
Journal:  J Mol Med (Berl)       Date:  2022-05-24       Impact factor: 5.606

Review 2.  Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.

Authors:  Gabor M Rubanyi
Journal:  Mol Ther       Date:  2013-02-12       Impact factor: 11.454

Review 3.  Novel molecular targets for coronary angiogenesis and ischemic heart disease.

Authors:  Brittany A Potz; Anshul B Parulkar; Ruhul M Abid; Neel R Sodha; Frank W Sellke
Journal:  Coron Artery Dis       Date:  2017-11       Impact factor: 1.439

4.  Enhanced nanomagnetic gene transfection of human prenatal cardiac progenitor cells and adult cardiomyocytes.

Authors:  Mahendran Subramanian; Jenson Lim; Jon Dobson
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.